ETON (STOCKS)
Eton Pharmaceutcials, Inc. Common Stock
$32.150000
+0.560000 (+1.77%)
Prev close: $31.590000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Sean E. Brynjelsen
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $880.67M
- Employees
- 31
- P/E (TTM)
- -452.82
- P/B (TTM)
- 28.23
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$0.05 | $0.09 | -0.0418 | -45.53% |
|
Dec 2025 (Q4)
|
$0.06 | $0.09 | -0.0318 | -34.64% |
|
Sep 2025 (Q3)
|
$-0.07 | $0.09 | -0.1618 | -176.25% |
|
Jun 2025 (Q2)
|
$-0.10 | $-0.04 | -0.0626 | -167.38% |
Financial Statements
| Revenues | $86.93M |
| Benefits Costs and Expenses | $88.42M |
| Cost Of Revenue | $39.32M |
| Costs And Expenses | $88.42M |
| Gross Profit | $47.61M |
| Operating Expenses | $45.57M |
| Depreciation and Amortization | $4.16M |
| Research and Development | $8.48M |
| Other Operating Expenses | $34.95M |
| Operating Income/Loss | $2.04M |
| Income/Loss From Continuing Operations After Tax | -$1.48M |
| Income/Loss From Continuing Operations Before Tax | -$1.49M |
| Income Tax Expense/Benefit | -$11.00K |
| Net Income/Loss | -$1.48M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$1.48M |
| Net Income/Loss Available To Common Stockholders, Basic | -$1.48M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.05 |
| Basic Average Shares | 81,088,000 |
| Assets | $97.71M |
| Current Assets | $53.25M |
| Inventory | $14.47M |
| Other Current Assets | $38.78M |
| Noncurrent Assets | $44.47M |
| Fixed Assets | $372.00K |
| Intangible Assets | $43.74M |
| Other Non-current Assets | $355.00K |
| Liabilities | $67.10M |
| Current Liabilities | $44.18M |
| Accounts Payable | $13.49M |
| Other Current Liabilities | $30.69M |
| Noncurrent Liabilities | $22.92M |
| Equity | $30.62M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $30.62M |
| Liabilities And Equity | $97.71M |
| Net Cash Flow From Operating Activities | $15.84M |
| Net Cash Flow From Operating Activities, Continuing | $15.84M |
| Net Cash Flow From Investing Activities | -$12.92M |
| Net Cash Flow From Investing Activities, Continuing | -$12.92M |
| Net Cash Flow From Financing Activities | $1.81M |
| Net Cash Flow From Financing Activities, Continuing | $1.81M |
| Net Cash Flow | $4.73M |
| Net Cash Flow, Continuing | $4.73M |
| Comprehensive Income/Loss | -$1.48M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$1.48M |
| Other Comprehensive Income/Loss | $0.00 |